"We provide the highest level of medical and surgical eye care, enhancing the quality of our patients’ lives providing you and your family with compassionate personal care, utilizing the latest technology to diagnose and treat your condition."

During the past decade, R and R Eye Research, LLC conducted 24 clinical trials. In the 10-year time frame, 24 clinical trials started and 14 clinical trials were completed, i.e. on average, 58.3% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 12 clinical trials were completed. i.e. 120% of trials that started reached the finish line.

Out of the total clinical trials conducted in "R and R Eye Research, LLC" #1 sponsor was "Allergan" with 4 trials, followed by "Shire" with 3 trials sponsored, "Surface Ophthalmics, Inc." with 3 trials sponsored, "Aerie Pharmaceuticals" with 2 trials sponsored and "ForSight Vision5, Inc." with 2 trials sponsored. Other sponsors include 6 different institutions and companies that sponsored additional 14 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "R and R Eye Research, LLC" #1 collaborator was "Allergan" with 1 trials as a collaborator, "IQVIA Biotech" with 1 trials as a collaborator, "National Eye Institute (NEI)" with 1 trials as a collaborator and "National Institutes of Health (NIH)" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "R and R Eye Research, LLC" are "Dry Eye Disease" (4 trials), "Ocular Hypertension" (4 trials), "Dry Eye Syndromes" (2 trials), "Glaucoma, Open-Angle" (2 trials) and "Presbyopia" (2 trials). Many other conditions were trialed in "R and R Eye Research, LLC" in a lesser frequency.

Most popular intervention types in "R and R Eye Research, LLC" are "Drug" (20 trials), "Device" (5 trials), "Other" (4 trials), "Biological" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "Vehicle" (3 trials), "Bimatoprost" (2 trials), "PVP-I 0.6%" (2 trials) and "SHP640" (2 trials). Other intervention names were less common.

The vast majority of trials in "R and R Eye Research, LLC" are 25 trials for "All" genders.

Currently, there are NaN active trials in "R and R Eye Research, LLC". undefined are not yet recruiting, undefined are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 18 completed trials in R and R Eye Research, LLC, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in R and R Eye Research, LLC, 0 "Phase 1" clinical trials were conducted, 9 "Phase 2" clinical trials and 11 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 3 trials that are defined as “Not Applicable".